Lexicon Pharmaceuticals Incorporated (LXRX) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Lexicon Pharmaceuticals Incorporated Company Snapshot

Business Description:

Lexicon Pharmaceuticals Incorporated operates in the Pharmaceutical preparations sector. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. The Company has conducted Phase II clinical trials of four of its drug candidates: LX4211, LX1031, LX1032 and LX2931. In our complete report available for purchase the company is compared to: Accentia Biopharmaceuticals, Inc., Icagen, Inc. and Cortex Pharmaceuticals, Inc..

Lexicon Pharmaceuticals Incorporated

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): 1.71
(Figures in U.S. Dollars)

1 Week	2.1%	13 Weeks	16.8%

4 Weeks	47.0%	52 Weeks	-6.8%

Lexicon Pharmaceuticals Incorporated Key Data:

Ticker:	LXRX	Country:	UNITED STATES

Exchanges:	NAS	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	4,908,000 (Year Ending Jan 2011).	Employees:	290

Currency:	U.S. Dollars	Market Cap:	575,740,758

Fiscal Yr Ends:	December	Shares Outstanding:	337,677,864

Share Type:	Common	Closely Held Shares:	200,475,655

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.